These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 16509932)

  • 1. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
    Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
    Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha.
    Ohashi N; Yonemura K; Sugiura T; Isozaki T; Togawa A; Fujigaki Y; Yamamoto T; Hishida A
    Am J Kidney Dis; 2003 Mar; 41(3):E10. PubMed ID: 12613003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect?
    Ravandi-Kashani F; Cortes J; Talpaz M; Kantarjian HM
    Cancer; 1999 Jun; 85(12):2583-8. PubMed ID: 10375106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukemia.
    Honda K; Ando A; Endo M; Shimizu K; Higashihara M; Nitta K; Nihei H
    Am J Kidney Dis; 1997 Jul; 30(1):123-30. PubMed ID: 9214412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
    Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E
    Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal thrombotic microangiopathy associated with interferon-alpha treatment of chronic myeloid leukemia.
    Magee CC; Abraham K; Farrell J; Dorman T; Walshe JJ
    Am J Kidney Dis; 2000 Jul; 36(1):E5. PubMed ID: 10873904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
    Bremer CT; Lastrapes A; Alper AB; Mudad R
    Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
    Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
    Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemolytic uremic syndrome-like episode following nonmyeloablative hematopoietic stem cell transplantation in a patient with chronic myeloid leukemia].
    Takahashi N; Miura I; Kume M; Kawabata Y; Hirokawa M; Sawada K
    Rinsho Ketsueki; 2003 Jun; 44(6):391-5. PubMed ID: 12884818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alpha sensitisation induced fatal renal insufficiency in a patient with chronic myeloid leukaemia: case report and review of literature.
    Colovic M; Jurisic V; Jankovic G; Jovanovic D; Nikolic LJ; Dimitrijevic J
    J Clin Pathol; 2006 Aug; 59(8):879-81. PubMed ID: 16873566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with lymphoblastoid alpha interferon in patients with chronic myeloid leukemia refractory to recombinant interferon alpha 2].
    Steegmann JL; Granados E; Vázquez L; de la Cámara R; Peñarrubia MJ; Fernández-Contreras E; Quiroga JA; Fernández Rañada JM
    Sangre (Barc); 1998 Oct; 43(5):443-6. PubMed ID: 9868341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic myelogenous leukemia with long-term hypoplasia induced by alpha-interferon and hydroxyurea].
    Motomura S; Sakai R; Tomita N; Fujimaki K; Hattori M; Fujisawa S; Mohri H; Takahashi N; Maruta A; Kodama F; Okubo T
    Rinsho Ketsueki; 1998 Apr; 39(4):302-7. PubMed ID: 9597898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alpha interferon in children with Philadelphia chromosome-positive chronic myeloid-leukaemia].
    Ben Lakhal R; Aissaoui L; Jeddi R; Ayari B; Ben Abid H; Belhadj Ali Z; Gouider E; Meddeb B; Hafsia R; Hafsia A
    Tunis Med; 2005 May; 83(5):296-9. PubMed ID: 16044905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of chronic myeloid leukemia with interferon-alpha].
    Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
    Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kidney biopsy is clearly mandatory to confirm the indication of plasma exchanges in adult haemolytic uraemic syndrome.
    Pourrat O; Touchard G; Robert R; Badia P; Bauwens M; Hauet T; Patte D
    Ann Med Interne (Paris); 1994; 145(5):369-72. PubMed ID: 7985952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy.
    Shah M; Jenis EH; Mookerjee BK; Schriber JR; Baer MR; Herzig GP; Wetzler M
    Cancer; 1998 Nov; 83(9):1938-46. PubMed ID: 9806652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
    Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
    Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of interferon-alpha in the treatment of chronic myeloid leukemia.
    Kujawski LA; Talpaz M
    Cytokine Growth Factor Rev; 2007; 18(5-6):459-71. PubMed ID: 17703986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.
    Goto H; Tsurumi H; Hara T; Moriwaki H
    Int J Hematol; 2000 Dec; 72(4):474-6. PubMed ID: 11197215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease.
    Breccia M; Cannella L; Stefanizzi C; Santopietro M; De Cuia R; Diverio D; Alimena G
    Leuk Res; 2009 May; 33(5):645-8. PubMed ID: 19062090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.